Quadrant Capital Group LLC

SEC CIK: 0001650717
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

DSGN holding history

Design Therapeutics, Inc. in every 13F filed by Quadrant Capital Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DSGN overview All 13F holders of DSGN Full Q2 2026 holdings

Shares (Q3 2023): 0; Sold out in Q3 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2023

Holdings of DSGN by Quadrant Capital Group LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2023	0	$0	0.0%	−362−100.0%	Sold out	Holders
Q2 2023	362	$2.28K	<0.1%	−254−41.2%	Reduced	Holders
Q1 2023	616	$3.56K	<0.1%	+616	New	Holders